Results

Total Results: 3,881 records

Showing results for "phase".

2641. Psn-Pdf (pdf file)
      psnet.ahrq.gov/node/49810/psn-pdf
      November 01, 2017 - First, it highlights that the last phase of most people's lives is an extended period of geriatric multimorbidity

2642. Appendix I. Measure Mapping Strategy | Agency for Healthcare Research and Quality
      www.ahrq.gov/ncepcr/care/coordination/atlas/appendix1.html
      June 01, 2014 - coordination issues during the period of diagnosis are likely similar to those during the treatment phase

2643. Pain Management Injection Therapies for Low-back Pain: Topic Refinement (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/lbpinject-topicref.pdf
      March 03, 2014 - return to work.7 In those with persistent symptoms, continued improvement is often seen in the subacute phase

2644. Spotlight (pdf file)
      psnet.ahrq.gov/sites/default/files/2020-05/final_may-spotlight-fatal_pca_slides_05.01.2020_cme_review-revised.pdf
      January 01, 2020 - Multimodal Analgesic Protocol and Postanesthesia Respiratory Depression During Phase I Recovery After

2645. STATISTICAL BRIEF #498: Out-of-Pocket Expenditures for Adults with Health Care Expenses for Multiple Chronic Conditions, U.S. Civilian Noninstitutionalized Population, 2014
      meps.ahrq.gov/data_files/publications/st498/stat498.shtml
      February 01, 2017 - persistent and have long lasting effects that impact one's ability to function well beyond an acute phase

2646. Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/major-depressive-disorder/research

2647. Untitled (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
      December 01, 2015 - Efficacy of Immunotherapy with TG4040, Peg-Interferon, and Ribavirin in a Phase 2 Study of Patients … Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients … Di Bisceglie et al.2014 Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase … We performed a phase II open-label study to determine the efficacy, safety, and immunotherapeutic properties

2648. Untitled (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
      December 01, 2015 - Efficacy of Immunotherapy with TG4040, Peg-Interferon, and Ribavirin in a Phase 2 Study of Patients … Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients … Di Bisceglie et al.2014 Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase … We performed a phase II open-label study to determine the efficacy, safety, and immunotherapeutic properties

2649. Archived: Final Evidence Summary: Obesity in Adults: Screening and Management | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary38/obesity-in-adults-screening-and-management-2012
      October 15, 2011 - Weight loss could be maintained for an additional year or more after completion of an active weight-loss phase … example, pros and cons of weight loss), self-monitoring, incentives, or support after active intervention phase … Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. … Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase

2650. Maximizing the Effectiveness of E-Prescribing Between Physicians and Community Pharmacies (pdf file)
      digital.ahrq.gov/sites/default/files/docs/publication/u18hs016394-lapane-final-report-2006.pdf
      January 01, 2006 - The requirements and analysis phase involves connectivity set up. … The next phase includes modification of the application. … In the initial phase, we implemented a protocol that resembled the baseline procedures (i.e. paper or

2651. Final Progress Report: Consumer-Led Workshop To Advance Patient Safety (pdf file)
      www.ahrq.gov/sites/default/files/2024-07/peck-report.pdf
      January 01, 2024 - Workshop participant evaluations suggest that the two-phase structure for the workshop worked very well

2652. Improving Patient Flow and Reducing Emergency Department Crowding: A Guide for Hospitals (pdf file)
      www.ahrq.gov/sites/default/files/publications/files/ptflowguide.pdf
      January 01, 2014 - The second phase is data abstraction. During this phase, data are harvested from the system. … The third and final phase is data reporting. Key decisions include how much to report and to whom.

2653. Disposition of Comments for Technical Brief 23 Genetic Testing (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/genetic-testing-developmental-disabilities_disposition-comments.pdf
      June 30, 2015 - We revised the phase as suggested. … program managed by Palmetto GBA is one of the gray literature sources that we explored in the early phase … Because the searches were updated during the peer review phase of the project, we have now added the … program managed by Palmetto GBA is one of the gray literature sources that we explored in the early phase

2654. Final Report -- State and Regional Demonstration in Health Information Technology: Rhode Island (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/state-regional-demonstration-hit-ri-final-report.pdf
      December 01, 2015 - project were not entirely as expected; the length of time required to develop and deploy the first phase … continuing its promotion of enrollment in the LTC community (for the remaining 35 percent) in the next phase … served as the basis for nearly all the State’s business and technical decisions during the development phase … Prior to the next phase of “user go live”, RIQI will train user organizations and, specifically, persons

2655. hemangioma-protocol-141223 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_research-protocol.pdf
      December 23, 2014 - exclusion criteria selected based on our understanding of the literature, input from the topic refinement phase … investigative team will also scan the reference lists of articles that are included after the full-text review phase

2656. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-2.pdf
      April 01, 2022 - outcomes of opioid-induced constipation in patients with chronic non-cancer pain in the compose phase … Effects of naltrexone exposure observed in two phase three studies with ALO-02, an extended-release … Measuring withdrawal in a phase 3 study of a new analgesic, nktr-181, in subjects with moderate to … Measuring Opioid Withdrawal in a Phase 3 Study of a New Analgesic, NKTR-181 (Oxycodegol), in Patients … A Phase I Placebo-Controlled Trial Comparing the Effects of Buprenorphine Buccal Film and Oral Oxycodone

2657. Evidence Summary: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/osteoporosis-screening
      January 14, 2025 - validation of a simple hip fracture risk prediction tool for type 2 diabetes: the Fremantle Diabetes Study phase … Liberman UA, Weiss SR, Bröll J, et al; Alendronate Phase III Osteoporosis Treatment Study Group. … osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase … Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with … dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase

2658. Introduction to Medication-Assisted Treatment | The Academy
      integrationacademy.ahrq.gov/products/playbooks/opioid-use-disorder/introduction-medication-assisted-treatment
      February 01, 2025 - An official website of the Department of Health & Human Services Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates The Academy Integrating Behavioral Health & Primary Care Expand Navi…

2659. Pharma-Nonpharma-Ptsd-2022-Update-App-G1 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-app-g1.xlsx
      January 01, 2022 - G-1. RoB 2 Assessment Table G-1. Risk of Bias 2 assessment of new included studies RoB Domain Bias Due to Randomization (Cochrane) or Selection Bias (AHRQ); Randomization Bias Due to Randomization (Cochrane) or Selection Bias (AHRQ); Allocation Bias Due to Randomization (Cochrane) or Selection Bias (AHRQ); Similarit…

2660. Right Patient, Wrong Sample | PSNet
      psnet.ahrq.gov/web-mm/right-patient-wrong-sample
      June 01, 2004 - Right Patient, Wrong Sample Citation Text: Astion ML. Right Patient, Wrong Sample. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Services. 2006. Copy Citation Format: Google Scholar BibTeX EndNote X3 XML EndNote 7 XML Endnote ta…